[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Protagonist Therapeutics, Inc (PTGX)
Protagonist Therapeutics (PTGX) stock is down XXXX% today amidst concerns about its new obesity drug. Social engagement remains high, suggesting potential for future growth.
About Protagonist Therapeutics, Inc
Protagonist Therapeutics, Inc. (PTGX) is a healthcare company focused on developing peptide-based drugs.
Protagonist Therapeutics, Inc uses the ticker $PTGX for trading. Listed in the Stocks and category within the Healthcare sectors.
Insights #
- Protagonist Therapeutics, Inc (PTGX) social dominance is up XXX% from the previous year.
- Protagonist Therapeutics, Inc (PTGX) galaxy score™ is up XXX% from the previous X months.
Price: $XXXXX #
Price 24-Hour Chart Data
The stock price decreased XXXX% today, likely due to concerns regarding the company's new obesity drug, despite high engagement on X, which may indicate the stock is currently undervalued.
| 24-Hour | 7-Day | 30-Day |
|---|---|---|
| -XXX% | XXXX% | XXXX% |
1-Year High: $XXXXX on 2025-03-11
1-Year Low: $XXXXX on 2025-02-25
AltRank: XXXXX #
AltRank 24-Hour Chart Data
Protagonist Therapeutics, Inc (PTGX) is currently AltRank #1,840 based on combined combined social and market metrics
Daily Average: XXX
1 Week: XXXXX +978
1 Month: XXXXX -XXX
1-Year High: XXXXX on 2025-06-18
1-Year Low: XX on 2025-03-11
Galaxy Score: XXXXX #
Galaxy Score 24-Hour Chart Data
Current Value: XXXXX
Daily Average: XX
1 Week: XX +17
1 Month: XX +18
1-Year High: XX on 2025-03-10
1-Year Low: XX on 2025-04-27
Engagements: XXXXX #
Engagements 24-Hour Chart Data
Current Value: XXXXX
Daily Average: XXXXX
1 Week: XXXXXX +5.80%
1 Month: XXXXXXX +384%
6 Months: XXXXXXXXX +165%
1 Year: XXXXXXXXX +100%
1-Year High: XXXXXXX on 2025-03-11
1-Year Low: XX on 2024-10-06
| Social Network | X | |
|---|---|---|
| Engagements | XXXXX | X |
Mentions: XX #
Mentions 24-Hour Chart Data
Current Value: XX
Daily Average: XX
1 Week: XXX -XX%
1 Month: XXXXX +968%
6 Months: XXXXX +355%
1 Year: XXXXX +496%
1-Year High: XXX on 2025-06-28
1-Year Low: X on 2024-10-06
| Social Network | X | |
|---|---|---|
| Mentions | XX | X |
Creators: XX #
Creators 24-Hour Chart Data
XX unique social accounts have posts mentioning Protagonist Therapeutics, Inc (PTGX) in the last XX hours which is down XX% from XX in the previous XX hours
Daily Average: XX
1 Week: XXX -XX%
1 Month: XXXXX +1,706%
6 Months: XXXXX +601%
1 Year: XXXXX +765%
1-Year High: XXX on 2025-06-28
1-Year Low: X on 2024-10-06
The most influential creators that mention Protagonist Therapeutics, Inc in the last XX hours
| Creator | Rank | Followers | Posts | Engagements |
|---|---|---|---|---|
| @definitely_not_vlad | X | XXXXXX | X | XXXXX |
| @bourr_ | X | XXXXXX | X | XXXXX |
| @Quantumup1 | X | XXXXX | X | XXXXX |
| @yodaez | X | XXXXXX | X | XXXXX |
Sentiment: XX% #
Sentiment 24-Hour Chart Data
Current Value: XX%
Daily Average: XX%
1 Week: XXX% no change
1 Month: XX% -XX%
6 Months: XX% +25%
1 Year: XX% -XX%
1-Year High: XXX% on 2024-07-19
1-Year Low: XX% on 2025-01-01
Most Supportive Themes
- Positive Sentiment and Upcoming Events: (9%) Posts show positive sentiment and high engagement, indicating optimism within the community and anticipation for upcoming events.
Most Critical Themes
- Neutral/Negative Sentiment: (91%) Protagonist Therapeutics is facing a cautious outlook due to neutral or negative network engagements.
Network engagement breakdown:
| Network | Positive | % | Neutral | % | Negative | % |
|---|---|---|---|---|---|---|
| X | XXXXX | XX% | XXXXX | XX% | X | X% |
| X | X% | X | X% | X | X% | |
| Total | XXXXX | XX% | XXXXX | XX% | X | X% |
Social Dominance: XXXXXXX% #
Social Dominance 24-Hour Chart Data
Current Value: XXXXXXX%
Daily Average: XXXX%
1 Week: XXXXXXX% +0.00193%
1 Month: XXXXX% +0.0067%
6 Months: XXXXX% +0.021%
1 Year: XXXXX% +0.022%
1-Year High: XXXXX% on 2025-03-12
1-Year Low: XXXXXX% on 2024-10-06
Market Dominance: XXXXXXX% #
Market Dominance 24-Hour Chart Data
Current Value: XXXXXXX%
Daily Average: X%
1-Year High: XXXXX% on 2025-03-31
1-Year Low: XXXXXXX% on 2025-02-27
Market Cap: $XXXXXXXXXXXXX #
Market Cap 24-Hour Chart Data
Current Value: $XXXXXXXXXXXXX
Daily Average: $XXXXXXXXXXXXX
1 Week: $XXXXXXXXXXXXX +$4.20%
1 Month: $XXXXXXXXXXXXX +$2.40%
1-Year High: $XXXXXXXXXXXXX on 2025-03-11
1-Year Low: $XXXXXXXXXXXXX on 2025-02-27
Top assets mentioned In the posts about Protagonist Therapeutics, Inc in the last XX hours
Strategy (MSTR) Akropolis (AKRO) Eli Lilly and Company (LLY) Strategy (MSTR) Sea Limited (SE) Vistra, Corp. (VST) Johnson & Johnson (JNJ) Williams Companies Inc (WMB) GSK plc (GSK)
Top topics mentioned In the posts about Protagonist Therapeutics, Inc in the last XX hours
spx, pltr, qqq, mstr, $mstr, $vrna, $abs, $sndx, $glpg, $akro, $lly, stocks, op, nvda, vera, $vrdn, $vtyx, strategy, srm, $se, $mctr, $vst, jnj, $jnj, ibkr, $qntm, $mirm, $tak, $cdtx, $wint, $wmb, $gsk, meta, $avir, ato, $gtec, $apei, bmnr, hims, aur, $1b, candle, abbv, dawn, $aeva, stocks healthcare, $foa, $mdgl, $axsm, stocks financial services, $pmo, poc, $mltx, $argx, $mrus, $pltr, $tmci, $asa, wen, $nage, $orgo, $bzai, okta, $mhla, $veon, $ttc, $astc, $elme, $codx, $lidr, pki, hum, $pki, $qqqput, barbadian or bajan dollar, ogn, amg, crcl, $nuwe, $cmrx, $cdmo, $capr, $bkha, $myi, $qncx, $lvlu, $mvf, $cvr, $arr, $baccu, $neu, $cheb, cfg, mny, $evg, $cion, iot, sim, hwm, qbts
Top Social Posts #
Top posts by engagements in the last XX hours
Showing only X posts for non-authenticated requests. Use your API key in requests for full results.
"Citizens reiterated $ABVX at a Market Outperform rating a $XX PT and a High-Conviction name after its confidence in the pot'l for +VE obefazimod Ph3 results in moderate-to-severe ulcerative colitis were reinforced by its #KOL call" $PTGX - $JNJ $VTYX $LLY $PFE Citizens added "On Wednesday we hosted Dr. Marla Dubinsky a gastroenterologist at Mt. Sinai and an IBD #KOL for a discussion on the upcoming Phase X results for obefazimod in ulcerative colitis. Dr. Dubinsky is encouraged about the potential for positive results for obefazimod in moderate-to-severe ulcerative colitis due to the positive"
@Quantumup1 on X 2025-07-18 11:05:09 UTC 3520 followers, 1839 engagements
"Many investors have made huge fortunes by following @Rekaulang6' stocks trading patterns.👍 $DARE $SONN $SQFT $SDST $OP $MAGM $VSEE $ALBT $CLIK $WINT $YHC $RBNE $VBTX $CVKD $RANI $SBET $OCTO $CPA $ENS $AFG $MITP $HOVNP $PTGX"
@Maximoe__lemo on X 2025-07-18 04:14:57 UTC X followers, XXX engagements
"$SYRE has long t1/2 IL23 ab in development. Likely to show efficacy at 3-6 months dosing. $JNJ and $PTGX has oral peptide IL23 antagonist about to be approved. Daily pill. If I bet I would imagine sc shot q 3-6 months is more convenient than daily pill. $ABBV skyrizi still dominant for IBD. Will less frequent ab from $SYRE particularly in combination with other targeted abs become serious contender ( data not out yet bispecific abs in development too )"
@bioinvestor24 on X 2025-07-18 03:09:17 UTC 3596 followers, XXX engagements
"I made $16307 this week with the help of @Yzq_hpp775. Their strategy is simple to understand and works great. Awesome 🌹🍂 $PRCT $WHLR $GOGL $APAM $FMAO $LOW $POWW $NLOP $BBU $LGCY $TOWN $EXOZ $EBTC $HUBC $MBC $GLP $PMEC $GPOR $LIDR $CODX $ELME $PTGX $ESAB $ASTC $TTC"
@AlexandraD6932 on X 2025-07-17 17:50:26 UTC X followers, XXX engagements